iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

L&T Technologies, Nvidia to develop AI-enabled architecture for medical devices

21 Nov 2023 , 09:20 AM

According to a regulatory filing, L&T Technology Services Ltd (LTTS) has collaborated with Nvidia to build AI-enabled, software-defined architectures for medical devices focused on endoscopy, which will improve picture quality and scalability.

With the aid of a scalable platform that supports many applications, the solution intends to overcome industry-wide issues of availability, cost, and dependencies tied to bespoke and proprietary hardware components, giving a real-time decision-making tool for the medical fraternity.

It claims low-latency data transfer, improved image processing without performance bottlenecks, and scalability, in addition to a user-friendly interface and seamless integration of the image processing pipeline for visualisation.

The partnership makes use of the Nvidia Holoscan and Nvidia IGX Orin platforms, which have ultra-low data transmission latency, better image processing, and scalability to support a variety of AI-enabled applications.

According to Amit Chadha, CEO and managing director of L&T Technology Services, the platform speeds up the development of AI-powered medical imaging solutions by boosting picture quality and real-time clinical decision-making assistance, making physicians more efficient and improving patient outcomes.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • L&T Technology
  • Larsen & Toubro
  • LTTS
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp